Merck to stop phase 3 HYPERION trial evaluating Winrevair early and move to final analysis: Rahway, New Jersey Friday, January 31, 2025, 10:00 Hrs [IST] Merck, known as MSD outsid ...

Chugai Pharm signs collaboration agreement with GSK's Global Health Unit for development of anti-dengue virus antibody: Tokyo Friday, January 31, 2025, 09:00 Hrs [IST] Chugai Phar ...

Shardul Nautiyal, Mumbai Friday, January 31, 2025, 08:00 Hrs [IST] ...

Peethaambaran Kunnathoor, Chennai Friday, January 31, 2025, 08:00 Hrs [IST] ...

Healthcare sector faces challenges in leprosy elimination with hidden cases & delayed detection: Nandita Vijayasimha, Bengaluru Friday, January 31, 2025, 08:00 Hrs [IST] Indian he ...

Dr Geethika Nutakki: Shardul Nautiyal, Mumbai Friday, January 31, 2025, 08:00 Hrs [IST] India is on the brink of a healthcare ...

Our Bureau, Mumbai Thursday, January 30, 2025, 17:40 Hrs [IST] ...

Biosciences receives US FDA orphan drug designation for MB-105 to treat relapsed/refractory CD5-positive T-cell lymphoma: Houston Thursday, January 30, 2025, 17:00 Hrs [IST] ...

Granules strengthens ADHD portfolio with US FDA approval for lisdexamfetamine dimesylate capsules: Our Bureau, Bengaluru Thursday, January 30, 2025, 16:15 Hrs [IST] Granules India ...

Quantum-Si and IDEX Health & Science partner to develop & manufacture optics module for Proteus instrument: Branford, Connecticut Thursday, January 30, 2025, 16:00 Hrs [IST] Quant ...

Professional development programme in digital health for nurses launched to empower nurses in India: Our Bureau, Mumbai Thursday, January 30, 2025, 15:40 Hrs [IST] Recognizing the ...

Developmental behavioural paediatrician Dr Samir H Dalwai highlights strategies that actually work for autism: Our Bureau, Mumbai Thursday, January 30, 2025, 15:25 Hrs [IST] In a ...